AU462722B2 - Pharmaceutical powder composition for inhalation - Google Patents
Pharmaceutical powder composition for inhalationInfo
- Publication number
- AU462722B2 AU462722B2 AU43805/72A AU4380572A AU462722B2 AU 462722 B2 AU462722 B2 AU 462722B2 AU 43805/72 A AU43805/72 A AU 43805/72A AU 4380572 A AU4380572 A AU 4380572A AU 462722 B2 AU462722 B2 AU 462722B2
- Authority
- AU
- Australia
- Prior art keywords
- inhalation
- powder composition
- pharmaceutical powder
- pharmaceutical
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB29207/71 | 1971-06-22 | ||
GB2920771A GB1381872A (en) | 1971-06-22 | 1971-06-22 | Pharmaceutical compositions for inhalation |
Publications (2)
Publication Number | Publication Date |
---|---|
AU4380572A AU4380572A (en) | 1974-01-03 |
AU462722B2 true AU462722B2 (en) | 1975-07-03 |
Family
ID=10287853
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU43805/72A Expired AU462722B2 (en) | 1971-06-22 | 1972-06-22 | Pharmaceutical powder composition for inhalation |
Country Status (9)
Country | Link |
---|---|
JP (1) | JPS5046820A (en) |
AU (1) | AU462722B2 (en) |
CA (1) | CA970685A (en) |
DE (1) | DE2229981C3 (en) |
DK (1) | DK134970B (en) |
FR (1) | FR2143163B2 (en) |
GB (1) | GB1381872A (en) |
NL (1) | NL176743C (en) |
ZA (1) | ZA723999B (en) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2332663C2 (en) * | 1973-06-23 | 1986-07-31 | Schering AG, 1000 Berlin und 4709 Bergkamen | Use of corticosteroid active ingredients for inhalation therapy |
GB1520247A (en) * | 1974-08-10 | 1978-08-02 | Fisons Ltd | Pelletised medicament formulations |
GB1571629A (en) * | 1977-11-30 | 1980-07-16 | Fisons Ltd | Pharmaceutical compositions containing beclomethasone dipropionate |
JPS6034925B2 (en) * | 1979-07-31 | 1985-08-12 | 帝人株式会社 | Long-acting nasal preparation and its manufacturing method |
EP0266443B1 (en) * | 1986-11-03 | 1993-06-23 | Allen W. Jacobs | Process for the inclusion of a solid particulate component into aerosol formulations of inhalable nicotine |
BE891013A (en) * | 1980-11-05 | 1982-05-05 | Fisons Ltd | PHARMACEUTICAL COMPOSITIONS |
IT1220979B (en) * | 1981-06-04 | 1990-06-21 | Lofarma Farma Lab | CAPSULES CONTAINING AN ALLERGEN AND PROCEDURE FOR THEIR PREPARATION |
JPS59163313A (en) * | 1983-03-09 | 1984-09-14 | Teijin Ltd | Peptide hormone composition for nasal administration |
GB9322014D0 (en) | 1993-10-26 | 1993-12-15 | Co Ordinated Drug Dev | Improvements in and relating to carrier particles for use in dry powder inhalers |
GB9404945D0 (en) | 1994-03-15 | 1994-04-27 | Glaxo Group Ltd | Pharmaceutical composition |
DE4425255A1 (en) * | 1994-07-16 | 1996-01-18 | Asta Medica Ag | Formulation for inhalation application |
GB9501841D0 (en) | 1995-01-31 | 1995-03-22 | Co Ordinated Drug Dev | Improvements in and relating to carrier particles for use in dry powder inhalers |
GB9515182D0 (en) | 1995-07-24 | 1995-09-20 | Co Ordinated Drug Dev | Improvements in and relating to powders for use in dry powder inhalers |
ITMI991582A1 (en) | 1999-07-16 | 2001-01-16 | Chiesi Farma Spa | DUST CONSTITUTED FROM PARTICLES HAVING THE PERFECTLY SMOOTH SURFACE FOR USE AS VEHICLES FOR THE PREPARATION OF INALA MIXTURES |
JP4691298B2 (en) * | 1999-10-12 | 2011-06-01 | 科研製薬株式会社 | Powder inhalation preparation and method for producing the same |
GB0009469D0 (en) | 2000-04-17 | 2000-06-07 | Vectura Ltd | Improvements in or relating to formalities for use in inhaler devices |
PE20011227A1 (en) | 2000-04-17 | 2002-01-07 | Chiesi Farma Spa | PHARMACEUTICAL FORMULATIONS FOR DRY POWDER INHALERS IN THE FORM OF HARD AGGLOMERATES |
DK1913939T3 (en) | 2000-06-27 | 2017-09-18 | Vectura Ltd | Formulations for use in inhalers |
EP3269360A1 (en) | 2000-11-30 | 2018-01-17 | Vectura Limited | Method of making particles for use in a pharmaceutical composition |
DE60140268D1 (en) | 2000-11-30 | 2009-12-03 | Vectura Ltd | PARTICLES FOR USE IN A PHARMACEUTICAL COMPOSITION |
TW200524577A (en) | 2003-11-04 | 2005-08-01 | Glaxo Group Ltd | Muscarinic acetylcholine receptor antagonists |
PE20060259A1 (en) | 2004-04-27 | 2006-03-25 | Glaxo Group Ltd | QUINUCLIDINE COMPOUNDS AS ANTAGONISTS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR |
JP5156397B2 (en) | 2005-02-10 | 2013-03-06 | グラクソ グループ リミテッド | Method for producing lactose using preclassification technology and pharmaceutical preparation formed from the lactose |
PT2400950T (en) | 2009-02-26 | 2019-08-29 | Glaxo Group Ltd | Pharmaceutical formulations comprising 4-{(1 r)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol |
GB0921075D0 (en) | 2009-12-01 | 2010-01-13 | Glaxo Group Ltd | Novel combination of the therapeutic agents |
GB201305825D0 (en) | 2013-03-28 | 2013-05-15 | Vectura Ltd | New use |
EP3910324A1 (en) | 2018-08-07 | 2021-11-17 | Norton (Waterford) Limited | Application of raman spectroscopy for the manufacture of inhalation powders |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1122284A (en) * | 1965-03-19 | 1968-08-07 | Fisons Pharmaceuticals Ltd | Inhalation device |
GB1242211A (en) * | 1967-08-08 | 1971-08-11 | Fisons Pharmaceuticals Ltd | Pharmaceutical composition |
-
1971
- 1971-06-22 GB GB2920771A patent/GB1381872A/en not_active Expired
-
1972
- 1972-06-12 ZA ZA723999A patent/ZA723999B/en unknown
- 1972-06-13 CA CA144,512A patent/CA970685A/en not_active Expired
- 1972-06-15 NL NLAANVRAGE7208207,A patent/NL176743C/en active Search and Examination
- 1972-06-20 DE DE2229981A patent/DE2229981C3/en not_active Expired
- 1972-06-21 FR FR7222310A patent/FR2143163B2/fr not_active Expired
- 1972-06-21 DK DK309072AA patent/DK134970B/en not_active IP Right Cessation
- 1972-06-22 AU AU43805/72A patent/AU462722B2/en not_active Expired
-
1973
- 1973-05-08 JP JP48050403A patent/JPS5046820A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
NL176743B (en) | 1985-01-02 |
JPS5046820A (en) | 1975-04-25 |
DK134970B (en) | 1977-02-21 |
DE2229981C3 (en) | 1981-04-02 |
ZA723999B (en) | 1973-06-27 |
FR2143163B2 (en) | 1975-10-31 |
FR2143163A2 (en) | 1973-02-02 |
GB1381872A (en) | 1975-01-29 |
AU4380572A (en) | 1974-01-03 |
CA970685A (en) | 1975-07-08 |
NL7208207A (en) | 1972-12-28 |
NL176743C (en) | 1985-06-03 |
DE2229981A1 (en) | 1972-12-28 |
DK134970C (en) | 1977-07-18 |
DE2229981B2 (en) | 1980-07-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU462722B2 (en) | Pharmaceutical powder composition for inhalation | |
CA999202A (en) | Inhalator for drug powder compositions with a vortex | |
CA1027005A (en) | Inhaler for powdered medicament | |
AU482733B2 (en) | Pharmaceutical compositions | |
ZA73284B (en) | Pharmaceutical powder composition containing sodium cromoglycate | |
CA983854A (en) | Pharmaceutical composition containing nitroglycerin | |
IL40475A0 (en) | Novel tetrazole derivatives,their preparation and pharmaceutical compositions containing them | |
IE35991L (en) | Camphor-containing pharmaceutical composition | |
CA974170A (en) | Pharmaceutical compositions | |
ZA718326B (en) | Pharmaceutical composition | |
IL40828A0 (en) | Dibenzothiepin derivatives,their manufacture and pharmaceutical compositions containing them | |
IL41200A0 (en) | Substituted 3-amino-prop-1-enes,their preparation and pharmaceutical compositions containing them | |
IL40362A0 (en) | Novel 4-oxo-4h-1-benzopyran and-thiabenzopyran derivatives,their preparation and pharmaceutical compositions containing them | |
AU456733B2 (en) | Pharmaceutical compositions containing benzofuran derivatives | |
AU461136B2 (en) | Pharmaceutical composition | |
IL39337A0 (en) | Isoindoline derivatives,processes for their preparation and pharmaceutical compositions containing the same | |
IL39355A0 (en) | Androstan-17beta-yl-acrylonitrile derivatives,their preparation and pharmaceutical compositions containing them | |
IL39381A0 (en) | Rheadan-type alkaloids,their preparation and pharmaceutical compositions containing them | |
CA864527A (en) | Aerosol antiperspirant composition | |
IL38772A0 (en) | Amino-anthracene derivatives,their manufacture and pharmaceutical compositions containing them | |
CA1000283A (en) | Amino-indazole compounds, processes for making them and pharmaceutical compositions containing them | |
CA884857A (en) | Pharmaceutical composition | |
CA885421A (en) | Pharmaceutical composition | |
CA983859A (en) | Aerosol antiperspirant composition | |
IL39204A0 (en) | Novel aminophenylketone derivatives,processes for their preparation and pharmaceutical compositions containing the same |